Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 13, 2025 • 11:41 AM ET

Date/Time Source News Release
06/13/2025 08:00 AM EDT GlobeNewswire Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025
05/30/2025 09:00 AM EDT GlobeNewswire Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting
04/15/2025 08:00 AM EDT GlobeNewswire Processa Pharmaceuticals' Dr. David Young to Present at World Orphan Drug Congress USA 2025
03/18/2025 08:30 AM EDT GlobeNewswire Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
02/07/2025 08:00 AM EST GlobeNewswire Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
01/30/2025 05:17 PM EST GlobeNewswire Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
01/27/2025 08:30 PM EST GlobeNewswire Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
10/30/2024 04:15 PM EDT GlobeNewswire Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results
10/02/2024 04:05 PM EDT GlobeNewswire Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer
09/03/2024 08:00 AM EDT GlobeNewswire Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September
Page

Additional News

As of June 13, 2025 • 11:41 AM ET

Date/Time Source News Release
05/10/2025 05:30 AM EDT US Earnings Reports Expected earnings - Processa Pharmaceuticals Inc.
05/08/2025 06:48 PM EDT KlickAnalytics PCSA - Historical Price Movements Surrounding Earnings
05/08/2025 06:43 PM EDT KlickAnalytics PCSA - Historical Earnings Price Analysis
01/28/2025 02:00 AM EST SeekingAlpha Processa Pharmaceuticals prices $5M equity offering
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Processa Pharmaceuticals Inc.
10/31/2024 04:59 AM EDT SeekingAlpha Processa Pharmaceuticals GAAP EPS of -$1.03
10/15/2024 09:32 AM EDT Baystreet Biotech Advances Gain Momentum Amid October's Rising Breast Cancer Rates and Awareness Efforts
10/03/2024 08:30 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Reports Phase 2 Clinical Trial Dosing Has Commenced
10/02/2024 04:30 PM EDT SeekingAlpha Processa stock rallies 35% post-market on Phase 2 study update
09/03/2024 08:30 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Participate at the H.C. Wainwright 26th Annual Global Investment Conference, ESMO Congress 2024
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.